Thus, SMN protein deficiency leads to disruption of normal cytoskeleton development resulting in shorter axons in SMA patients, which may partly explain the lower NFs levels in SMA patients than in ALS patients. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.